Jaguar Health (NASDAQ:JAGX) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Jaguar Health (NASDAQ:JAGX) in a report published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock.

Jaguar Health Trading Down 7.2 %

NASDAQ:JAGX opened at $0.23 on Thursday. Jaguar Health has a one year low of $0.20 and a one year high of $21.60. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. The firm has a 50-day simple moving average of $0.73 and a 200-day simple moving average of $0.96.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Jaguar Health stock. Geode Capital Management LLC increased its position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) by 18.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,716 shares of the biotechnology company’s stock after acquiring an additional 14,895 shares during the quarter. Geode Capital Management LLC owned about 0.82% of Jaguar Health worth $98,000 as of its most recent SEC filing. Institutional investors own 12.04% of the company’s stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.